Cognivue Named “Top Cognitive Impairment Early Detection Solution 2025” and Featured as October Cover Story in Healthcare Tech Outlook
October 22, 2025
Cognivue® has been recognized by Healthcare Tech Outlook as the Top Cognitive Impairment Early Detection Solution for 2025, further solidifying its leadership in advancing timely cognitive assessment. To highlight the achievement, Healthcare Tech Outlook profiled Cognivue in a four-page cover story in its October issue, titled “Cognivue: Spot cognitive changes early, enable timely action.”
According to the publication:
“This award is in recognition of Cognivue’s stellar reputation and trust among customers and industry peers, evident in the numerous nominations we received from our subscribers. Cognivue emerged as the Top Cognitive Impairment Early Detection Solution 2025 after an exhaustive evaluation by an expert panel of C-level executives, industry thought leaders, and our editorial board.”
Cognivue Clarity® and Cognivue Thrive® are based on FDA-cleared technology, helping make early cognitive testing practical and accessible across clinical and community care settings. The Healthcare Tech Outlook feature spotlights Cognivue Clarity, a cognitive assessment tool that captures more than 130,000 data points per patient in its comprehensive 10-minute session— applying adaptive psychophysics to automatically adjust to each individual’s responses and deliver a precise, data-driven evaluation of cognitive performance.
CEO Perspective:
“Too often, cognitive change goes unrecognized until it begins to impact daily life,” said Paul W. Estes, President and CEO of Cognivue. “Cognivue’s FDA-cleared technology is designed to give clinicians practical, objective insight earlier—helping integrate cognitive assessment into routine care. This award reflects our ongoing commitment to research, innovation, and making early detection a reality across healthcare.”
Continuing to Expand the Reach of Early Detection
With clinical results from large-scale studies such as FOCUS, Bio-Hermes, and the development of a new metric, the Cognitive Amyloid Risk Measure (CARM*), Cognivue is setting a new standard for objective, scalable cognitive screening.
The full Healthcare Tech Outlook October 2025 issue is available now in both digital and print formats.
Read the feature article here: https://www.healthcaretechoutlook.com/cognivue
*patent pending
